Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_assertion type Assertion NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_head.
- NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_assertion description "[The development of novel technologies, such as massively parallel DNA sequencing, has led to the identification of several novel recurrent gene mutations, such as DNA methyltransferase (Dnmt)3a, ten-eleven-translocation oncogene family member 2 (TET2), isocitrate dehydrogenase (IDH)1/2, additional sex comb-like 1 (ASXL1), enhancer of zeste homolog 2 (EZH2) and ubiquitously transcribed tetratricopeptide repeat X chromosome (UTX) mutations in acute myeloid leukemia (AML) and other myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_provenance.
- NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_assertion evidence source_evidence_literature NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_provenance.
- NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_assertion SIO_000772 23760684 NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_provenance.
- NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_assertion wasDerivedFrom befree-2016 NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_provenance.
- NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_assertion wasGeneratedBy ECO_0000203 NP1085367.RA4RPm5uzHtZm3aT5yiw1D9WrHRqloEVDqIFdHtPt_P4g130_provenance.